Mutational findings in bulk, CD19-enriched, and CD33-enriched samples
| Mutation . | VAF, % . | ||
|---|---|---|---|
| Bulk sample . | CD19 fraction . | CD33 fraction . | |
| ASXL1 R693* | Not tested | Not detected | 51 |
| BCOR S499fs | 29 | 47 | Not detected |
| EZH2 R614I | 6 | Not detected | 32 |
| NRAS Q61L | 15 | 22 | Not detected |
| RUNX1 S322* | 5 | Not detected | 33 |
| U2AF1 Q157P | 43 | 49 | 49 |
| Mutation . | VAF, % . | ||
|---|---|---|---|
| Bulk sample . | CD19 fraction . | CD33 fraction . | |
| ASXL1 R693* | Not tested | Not detected | 51 |
| BCOR S499fs | 29 | 47 | Not detected |
| EZH2 R614I | 6 | Not detected | 32 |
| NRAS Q61L | 15 | 22 | Not detected |
| RUNX1 S322* | 5 | Not detected | 33 |
| U2AF1 Q157P | 43 | 49 | 49 |
Not detected = to a limit of detection of 3% variant allele fraction (VAF).